Xintela AB :
* Initiates study on treatment of cartilage damage in horses in the United States
* Goal of study is to determine if Xintela's stem cells are safe to use and are tolerated well by the horse under treatment
* Says study results are important in company's ambition to develop a stem cell product for horses but also to prepare for clinical studies in man Source text: bit.ly/1QwvpQZ Further company coverage: (Gdynia Newsroom)
0 nhận xét:
Đăng nhận xét